longbridgelongbridge
  • 平台特色
    特色
    投资产品私人财富管理交易工具行情服务分析工具资讯服务开发者平台
    账户类型
    个人客户机构客户
  • Café
longbridge
© 2026 Longbridge|服务条款隐私政策

Addex Therapeutics

ADXN

----
开始交易
概览概览新闻新闻讨论讨论财务财务预测预测估值估值股东股东简况简况
LongbridgeAI
全部股东机构持有者内部人士

全部股东

股东类型

  • 公众及其他79.63%
  • 个人与内部人士18.65%
  • 机构投资者1.72%

主要股东

主要股东 最新
股东
Timothy DyerCo-Founder, CEO & Director
14.12%1,684.90 万0.00%+02026/09/02
Vincent LawtonIndependent Chairman of the Board
2.10%250.80 万0.00%+02026/09/02
UBS Asset Management AG
1.64%195.77 万0.00%+02026/07/31
Raymond HillNon-Executive Director
1.14%136.55 万0.00%+02026/09/02
Roger MillsChief Medical Officer & Director
0.66%78.60 万0.00%+02026/09/02
Mikhail KalinichevHead of Translational Science
0.26%30.68 万0.00%+02026/09/02
Isaac MankeIndependent Director
0.18%21.96 万0.00%+02026/09/02
Jason NunnIndependent Director
0.18%21.96 万0.00%+02026/09/02
BlackRock, Inc.
0.07%8.46 万<0.01%+2,234.002026/07/31
Pictet Asset Management Limited
<0.01%5,000.000.00%+02025/09/30
SBI Holdings, Inc.
<0.01%120.000.00%+02026/06/30
Lénaic TeyssédouHead of Finance
0.00%0.00--+02026/05/15
GAMMA Investing LLC
0.00%0.00<0.01%-9,720.002026/06/30
Morgan Stanley
0.00%0.000.03%-3.61 万2026/06/30
Rhumbline Advisers Ltd Partnership
0.00%0.00<0.01%-8,640.002026/06/30